International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Similar documents
ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS

FORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS

ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF NIMESULIDE BY CYCLODEXTRINS, POLOXAMER AND PVP

EFFECT OF PVP ON CYCLODEXTRIN COMPLEXATION OF EFAVIRENZ FOR ENHANCING ITS SOLUBILITY AND DISSOLUTION RATE

ISSN: X CODEN: IJPTFI Available Online through Research Article

MEDAK DIST. ANDHRA PRADESH STATE, INDIA. Research Article RECEIVED ON ACCEPTED ON

FACTORIAL STUDIES ON THE EFFECTS OF HYDROXY PROPYL β- CYCLODEXTRIN AND POLOXAMER 407 ON THE SOLUBILITY AND DISSOLUTION RATE OF BCS CLASS II DRUGS

skim milk as carrier by kneading method. They were evaluated for percentage yield, drug content, FT-IR

STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS

Comparative Dissolution Study of Glipizide by Solid Dispersion Technique

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012

A FACTORIAL STUDY ON ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF IBUPROFEN BY β CYCLODEXTRIN AND SOLUTOL HS15

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES

Optimization of valsartan tablet formulation by 2 3 factorial design

Research Article Derivative Spectrophotometric Method for Estimation of Metformin Hydrochloride in Bulk Drug and Dosage Form

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Journal of Chemical and Pharmaceutical Research, 2018, 10(1): Research Article

Journal of Pharmaceutical and Scientific Innovation

INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES

Available online at

FORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER PVPK30 INCLUSION COMPLEXES

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF ACECLOFENAC BY SOLID DISPERSION IN STARCH PHOSPHATE AND GELUCIRE

Patel B et al. IRJP 1 (1)

Chemate and Chowdary, IJPSR, 2012; Vol. 3(7): ISSN:

Int. Res J Pharm. App Sci., 2013; 3(6):42-46 ISSN:

Development and validation of spectrophotometric method for simultaneous estimation of Sumatriptan and Naproxen sodium in tablet dosage form

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

Journal of Advanced Scientific Research. Formulation and Evaluation of Glimepiride Solid Dispersion Tablets for Their Solubility Enhancement

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD ESTIMATION OF TOLVAPTAN IN BULK PHARMACEUTICAL FORMULATION

EFFECT OF STARCH HYDROLYSATES IN THE PROCESS OF DISSOLUTION OF SOLIDS

Scholars Research Library. Formulation Development of Pioglitazone Tablets Employing β Cyclodextrin- Poloxamer 407- PVP K30: A Factorial Study

Int. Res J Pharm. App Sci., 2012; 2(6): ISSN:

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch

K. Ravi Shankar et al. /BioMedRx 2013,1(3), Available online through

FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS

Mixed Hydrotropy: Novel Science of Solubility Enhancement

Journal of Chemical and Pharmaceutical Research

Journal of Chemical and Pharmaceutical Research

CHAPTER VI FACTORIAL STUDIES ON THE EFFECTS OF CYCLODEXTRINS AND SOLUTOL HS15 ON THE SOLUBILITY AND DISSOLUTION RATE OF EFAVIRENZ AND RITONAVIR

Preparation and Characterization of Candesartan Cilexetil Solid Lipid Nanoparticulate Capsules

ENHANCEMENT OF SOLUBILITY, DISSOLUTION RATE AND BIOAVAILABILITY OF RITONAVIR BY CYCLODEXTRINS AND SOLUTOL HS15 - A FACTORIAL STUDY

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac

RP- HPLC and Visible Spectrophotometric methods for the Estimation of Meropenem in Pure and Pharmaceutical Formulations

Scholars Research Library

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

IMPAIRMENT OF THE IN VITRO RELEASE OF CARBAMAZEPINE FROM TABLETS

International Journal of Innovative Pharmaceutical Sciences and Research

Asian Journal of Pharmacy and Life Science ISSN Vol. 1 (4), Oct-Dec, 2011

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

DEVELOPMENT OF RP-HPLC METHOD FOR ESTIMATION OF DROTAVERINE HYDROCHLORIDE IN PHARMACEUTICAL FORMULATIONS

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN

DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL USING ARGININE CARBONATE

Development and Validation of a New Uv Method for the Analysis of Rebamipide

UV SPECTROPHOTOMETRIC METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF ATENOLOL AND LOSARTAN POTASSIUM BY Q-ANALYSIS

SOLID INCLUSION COMPLEXES OF CLASS II IMIDAZOLE DERIVATIVE WITH Β CYCLODEXTRIN. Pradesh.

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

Formulation and Evaluation of Tinidazole Syrup Made by Mixed Solvency Concept Technique

Journal of Chemical and Pharmaceutical Research

Journal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article

Immediate Release Formulation of Valsartan Capsule and Evaluation of its Compatibility by Nonthermal Methods

Available Online through Research Article

Design and Optimization of Rivaroxaban Lipid Solid Dispersion for Dissolution Enhancement using Statistical Experimental Design. ), and Labrasol (X 3

pharmaceutical formulations. Anagliptin shows absorption maximum at 246 nm and obeys beer s law in the

Validated UV Spectrophotometric Method Development And Stability Studies Of Acamprosate Calcium In Bulk And Tablet Dosage Form

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

Formulation and evaluation of Orodispersible tablets to enhance dissolution rate of Lamotrigine by using Solid Dispersion Technique

FORMULATION, EVALUATION AND OPTIMIZATION OF SOLID DISPERSION OF GLIPIZIDE USING FACE CENTERED CENTRAL COMPOSITE DESIGN

Enhancement of dissolution rate of slightly soluble drug Clomiphene Citrate by Solid Dispersion

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

IJRPC 2011, 1(4) Rohan et al. ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

FORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS

Validated Spectrophotometric Method for Simultaneous Estimation of Atorvastatin and Nicotinic acid in Combined Pharmaceutical dosage form

Available Online through Research Article

1. Gastric Emptying Time Anatomically, a swallowed drug rapidly reaches the stomach. Eventually, the stomach empties its content in the small

Int. Res J Pharm. App Sci., 2013; 3(4): ISSN:

The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Formulation and evaluation of fast dissolving tablet of aceclofenac

FORMULATION DEVELOPMENT OF RIVAROXABAN LIPID SOLID DISPERSION USING DIFFERENT TECHNIQUES FOR THE DISSOLUTION ENHANCEMENT

DEVELOPMENT AND VALIDATION OF COLORIMETRIC METHODS FOR THE DETERMINATION OF RITONAVIR IN TABLETS

REVERSE PHASE HPLC METHOD FOR THE ANALYSIS OF ALFUZOSIN HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORMS

SOLUBILITY OF SELECTED DERIVATIVES OF 1,4-BENZODIAZEPINE-2-ONE IN THE PRESENCE OF PVP

IJRPC 2014, 4(2), Vinod Kumar et al. ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

DEVELOPMENT AND VALIDATION OF NEW HPLC METHOD FOR THE ESTIMATION OF PALIPERIDONE IN PHARMACEUTICAL DOSAGE FORMS

Development and validation of UV-visible spectrophotometric method for estimation of rifapentine in bulk and dosage form

Comparative study of different solubility enhancement techniques on dissolution rate of zaltoprofen

Formulation Development of Nimesulide Tablets by Wet Granulation and Direct Compression Methods Employing Starch Citrate

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS TOLBUTAMIDE IN PURE AND PHARMACEUTICAL FORMULATIONS

Development, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by HPLC Method

Preparation and Evaluation of Ethyl Cellulose Coated Microcapsules of Carbamazepine for Controlled Release

PREPARATION AND EVALUATION OF STARCH - PEG 1500 CO-PROCESSED EXCIPIENT AS A NEW DIRECTLY COMPRESSIBLE VEHICLE IN TABLET FORMULATIONS

Formulation and Evaluation

Purity Tests for Modified Starches

FORMULATION AND EVALUATION OF FLOATING TABLETS OF NORFLOXACIN

Transcription:

Research Article CODEN: IJRPJK ISSN: 2319 9563 International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage: www.ijrpns.com COMPARARISSION OF SOLUBILITY IMPROVEMENT OF CEFIXIME AND OMEPRAZOLE MAGNESIUM BY SOLID DISPERSION AND SLUGGING METHOD S. Shahid Mohammed* 1, G. Venkatarajagopal Reddy 1, K. Viswaganga Pranush 1 1* Department of Pharmaceutics, Seven Hills College of Pharmacy, Tirupati-517561, Andhrapradesh, India. ABSTRACT The formulation of poorly soluble compounds for oral delivery at present is one of the most frequent and greatest challenges to formulation scientists in the pharmaceutical industry. comes under class II of BCS classification which means low solubility and high permeability. Cefixime comes under class IV of BCS classification which means for low solubility and low permeability. Low solubility of omeprazole and cefixime leads to bioavailability problems. Increasing the solubility of omeprazole and cefixime can increase the bioavailability of the drug. Solid dispersion and slugging method is employed to increase solubility of drug. The solid dispersion by solvent evaporation, and fusion method were prepared using PVPK-30, urea and PEG 6000, in ratios 1:1, 1:2 and 1:3.Slugging using excipient like lactose and sodium chloride in different ratios 1:1, 1:2 and 1:3 also enhances solubility of the drug. Solid dispersion with solvent evaporation technique (PVP-K: ethanol) showed higher drug solubility in comparison to other technique like slugging method and fusion method. Slugging method is next better alternative to improve solubility of the given drug. KEYWORDS Solid dispersion,, Cefixime and Slugging. Author for Correspondence: S. Shahid Mohammed, Department of Pharmaceutics, Seven Hills College of Pharmacy, Tirupati-517561, Andhrapradesh, India. Email: shahith_md@yahoo.co.in INTRODUCTION 1-5 The enhancement of oral bioavailability of poor water soluble drugs remains one of the most challenging aspects of drug development 1.Together with the permeability; the solubility behavior of a drug is a key determinant of its oral bioavailability. There have always been certain drugs for which solubility has presented a challenge to the development of a suitable formulation for oral administration. The formulation of poorly soluble Available online: www.uptodateresearchpublication.com January - February 50

compounds for oral delivery at present is one of the most frequent and greatest challenges to formulation scientists in the pharmaceutical industry. However, the most attractive option for increasing the release rate is improvement of the solubility through formulation approaches. Although salt formation, solubilization and particle size reduction have commonly been used to increase dissolution rate and thereby oral absorption and bioavailability of low water soluble drugs 2 4, there are practical limitation of these techniques. In 1961, Sekiguchiand Obi 5 developed a practical method whereby many of the limitations with the bioavailability enhancement of poorly water soluble drugs can be overcome. This method, which was later, termed solid dispersion which involved the formation of eutectic mixture of drugs with water soluble carriers by the melting of their physical mixtures. The present research was undertaken to improve solubility of omeprazole and cefixime by solid dispersion and slugging method. Cefixime comes under class IV of BCS classification which stands for low solubility and low permeability. Low solubility of cefixime leads to bioavailability problems of cefixime. Increasing the solubility of cefixime can increase the bioavailability of cefixime. comes under class II of BCS classification which stands for low solubility and high permeability. Low solubility of omeprazole leads to bioavailability problems of omeprazole.increasing the solubility of omeprazole can increase the bioavailability of omeprazole. MATERIAL AND METHODS 6-8 Material Cefixime and was obtained as a gift sample from DRL laboratories, Hyderabad. All other chemicals and reagents were of analytical grade. Method of estimation of Cefixime 6 A simple, fast, reproducible and precise method of estimation for cefixime was carried based on the solubility of cefixime in ethanol. The absorption maximum was found to be 234 nm. Beers range was found to be 2-26 μg/ml. Solubility measurements of cefixime were performed according to a published method. An excess amount of cefixime (50 mg) was added to 10 ml of aqueous solution of water soluble carriers like, PVPK 30, and PEG-6000 and slugs of lactose and sodium chloride in the various ratios such as 1:1, 1:2, and 1:3 in screw capped bottles. Samples were shaken for the 24 hours at room temperature. Subsequently, the suspensions were filtered through a Whatman filter paper no 1. Filtered solution diluted properly with ethanol. The diluted solution analyzed for the cefixime in UV 234 nm. Estimation of 6 A simple, fast, reproducible and precise method of estimation for was carried based on the solubility of omeprazole in ethanol. The absorption maximum was found to be 302nm. Beers range was found to be 2-26 μg/ml. Solubility measurements of were performed according to a published method (Higuchi and Connors, 1965). An excess amount of cefixime (50 mg) was added to 10 ml of aqueous solution of water soluble carriers like, PVPK 30, and PEG-6000 and slugs of lactose and sodium chloride in the various ratios such as 1:1, 1:2, and 1:3 in screw capped bottles Samples were shaken for the 24 hours at room temperature. Subsequently, the suspensions were filtered through a Whatman filter paper no 1. Filtered solution diluted properly with ethanol. The diluted solution analyzed for the in UV 302 nm. Preliminary solubility studies of Cefixime 7 Solubility measurements of cefixime were performed according to a published method Higuchi and Connors. An excess amount of cefixime (25mg) was added to 10 ml of aqueous solution of water in screw capped bottles. Samples were shaken for the 24 hours at room temperature. Subsequently, the suspensions were filtered through a Whatman filter paper no 1. Filtered solution diluted properly with distilled water. The diluted solution analyzed for the cefixime in UV 234 nm. Available online: www.uptodateresearchpublication.com January - February 51

Preliminary solubility studies of 7 Solubility measurements of were performed according to a published method Higuchi and Connor. An excess amount of (25mg) was added to 10 ml of aqueous solution of water in screw capped bottles. Samples were shaken for the 24 hours at room temperature. Subsequently, the suspensions were filtered through a Whatman filter paper no 1. Filtered solution diluted properly with distilled water. The diluted solution analyzed for the in UV 302 nm. Preparation of solid dispersions of Cefixime and 7-8 Solid dispersion is one of the most commonly used techniques to improve the solubility of water insoluble drugs which in turn improves the bioavailability. Solid dispersions were prepared by hot melt method (PEG 6000) and solvent evaporation methods (PVPK-30, ). In hot melt method, the insoluble drug is dispersed into a molten carrier and cooled immediately. In solvent evaporation method, both drug and the carrier were dissolved in a common volatile solvent (ethanol), and the solvent was evaporated to get solid dispersions. The drug is practically water insoluble molecule. In order to improve its solubility in water solid dispersions were prepared. Hot melt method 7-9 In hot melt method, the carriers such as PEG 6000 were selected based on the preliminary solubility study. The drug to polymer ratio was kept 1:1, 1:2, and 1:3. The carrier was first melted in the water bath at about 60 o C and the drug was dispersed when molten mass is being cooled in cooled water bath with constant stirring. The dispersion was poured and cooled immediately. The solid dispersions obtained from this method were tacky enough. Solvent evaporation method 7-9 In solvent evaporation method, drug and the carrier were dissolved in ethanol and were dispersed in the same medium with constant stirring. Solution was evaporated under low pressure to get the solid dispersion. In this method PVP-K-30 and urea was used as carriers. Drug: carrier ratio was kept 1: 1, 1: 2 and 1:3 respectively. Slugging method 7-9 Drug (cefixime and omeprazole ) were mixed with excipient (lactose and sodium chloride) in different ratios (1:1, 1:2and, 1:3)and allowed to slug using single station tablet compressing machine under high pressure. The slugs formed were powdered using mortar and pestle and passed through sieve 80#. The solubility of drug in 10ml water was determined. Solubility studies of cefixime 8 Solubility measurements of cefixime were performed according to a published method Higuchi and Connors. Samples were mixed with 10 ml of distilled water and shaken for the 24 hours at room temperature. Subsequently, the suspensions were filtered through a Whatman filter paper no 1. Filtered solution diluted properly with distilled water. The diluted solution analyzed for the cefixime in UV 234 nm. Solubility studies of omeprazole 8 Solubility measurements of omeprazole were performed according to a published method Higuchi and Connors. Samples were mixed with 10 ml of distilled water and shaken for the 24 hours at room temperature. Subsequently, the suspensions were filtered through a Whatman filter paper no 1. Filtered solution diluted properly with distilled water. The diluted solution analyzed for the omeprazole in UV 302 nm Evaluation of solid dispersion 10 Solid dispersions obtained from the above methods were screened for their solubility. Drug content The amount of drug present in a 50 mg equivalent amount of solid dispersion and slugging was determined by, dissolving the powder mixture in 10 ml of ethanol and suitably diluted with ethanol and UV absorbance was measured. Drug concentration was determined from standard graph. Similarly drug dispersion concentrations were calculated in water using ethanol as solvent. Available online: www.uptodateresearchpublication.com January - February 52

RESULTS AND DISCUSION Standard graph for Cefixime Cefixime was found to be soluble in organic solvents such as methanol. A simple reproducible method of estimation was carried out in methanol ranging from 2-26 µ/ml solutions at 234nm in Table No.1-3 against the blank the standard graph obtained was linear was shown in Figure No.1. Cefixime is insoluble in water and having poor bioavailability and coming under the category of class 4 of biopharmaceutical classification (BCS) system Standard graph for was found to be soluble in organic solvents such as ethanol. A simple reproducible method of estimation was carried out in ethanol ranging from 2-26 µ/ml solutions at 302 nm in Table No.4 against the blank the standard graph obtained was linear was shown in Figure No.2 is very slightly soluble in water and having poor bioavailability and coming under the category of class 2 of biopharmaceutical classification system. Saturation solubility The saturation solubility of cefixime and omeprazole by solid dispersion and slugging and its solubility of in water are presented in Table No.5-6. DISCUSSION The percentage increase in saturation solubility with PVPK-30 and urea was higher than other polymers and techniques. This shows that solid dispersion using solvent evaporation technique gives a better solubity of drug when compared to other techniques. This might be due to the better solubilization effect of drug and polymer with solvent over PEG-6000 and slugging method. Slugging method is next best alternative for increasing solubility of drug. Table No.1: Physical characteristics and solubility studies of Cefixime S.No Drug Carrier Ratio Method of preparation 1 Cefixime 2 Cefixime 3 Cefixime 4 Cefixime 5 Cefixime 6 Cefixime 7 Cefixime 8 9 Cefixime 10 Cefixime PVP K-30 1:1 PVP K-30 1:2 PVP K-30 1:3 1:1 1:2 1:3 PEG-6000 1:1 Cefixime PEG-6000 1:2 PEG-6000 1:3 Lactose 1:1 Slugging method Available online: www.uptodateresearchpublication.com January - February 53

11 Cefixime Lactose 1:2 Slugging method) 12 Cefixime Lactose 1:3 Slugging method 13 Cefixime Sodium chloride 1:1 Slugging method 14 Cefixime Sodium chloride 1:2 Slugging method 15 Cefixime Sodium chloride 1:3 Slugging method Table No.2: Physical characteristics and solubility studies of omeprazole S.No Drug Carrier Ratio Method of preparation 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 PVP K-30 1:1 PVP K-30 1:2 PVP K-30 1:3 1:1 1:2 1:3 PEG-6000 1:1 PEG-6000 1:2 PEG-6000 1:3 Lactose 1:1 Slugging method Lactose 1:2 Slugging method Lactose 1:3 Slugging method Sodium chloride 1:1 Slugging method Sodium chloride 1:2 Slugging method Sodium chloride 1:3 Slugging method Available online: www.uptodateresearchpublication.com January - February 54

Table No.3: Standard graph of Cefixime S.No Concentration (µg / ml) Absorbance (nm) 1 0 0.0000 2 5 0.106 3 10 0.209 4 15 0.316 5 20 0.423 6 25 0.502 Table No.4: Standard graph of S. No Concentration (µg / ml) Absorbance (nm) ±SD 1 0 0.0000 0.00 2 2 0.0847 ± 0.0613 3 4 0.1750 ± 0.0140 4 6 0.2443 ± 0.0176 5 8 0.3163 ± 0.0146 6 10 0.3940 ± 0.0166 7 12 0.4707 ± 0.0150 8 14 0.5457 ± 0.0255 9 16 0.6527 ± 0.0350 10 18 0.7410 ± 0.0125 11 20 0.8100 ± 0.0234 12 22 0.8870 ± 0.0276 13 24 0.9663 ± 0.0234 14 26 1.0803 ± 0.0155 Available online: www.uptodateresearchpublication.com January - February 55

Table No.5: Solubility of Cefixime in water S.No Solid dispersion formulations Ratio Absorbance (nm) Saturation solubility in distilled water (µg/ml) 1. Cefixime + ethanol 0.876 50.0 (100%) 2. 3. Cefixime + water Cefixime +PVP K-30 0.197 11.2 (22%) 1:1 0.778 44.0 (88%) 4. 5. Cefixime +PVP K-30 1:2 0.860 49.1 (97%) Cefixime +PVP K-30 1:3 0.875 49.9 (98%) 7 8 9 Cefixime + Cefixime + Cefixime + 1:1 0.820 46.8 (93%) 1:2 0.875 37.6 (99%) 1:3 0.875 37.6 (99%) 7. 8. 9. Cefixime + PEG-6000 1:1 0.542 30.9 (62 %) Cefixime + PEG -6000 1:2 0.562 32.1 (64 %) Cefixime + PEG-6000 1:3 0.564 32.2 (64%) 13 Cefixime + lactose 1:1 0.688 43.8 (79%) 14 Cefixime + lactose 1:2 0.702 40.1 (80 %) 15 Cefixime + lactose 1:3 0.702 40.1 (80 %) 16 Cefixime + sodium chloride 1:1 0.684 39.0 (78%) 17 Cefixime + sodium chloride 1:2 0.634 36.2 (81%) 18 Cefixime + sodium chloride 1:3 0.602 34.4 (53%) Available online: www.uptodateresearchpublication.com January - February 56

Table No.6: Solubility of in water S. No Solid dispersion formulations Ratio 1. 2. 3. 4. 5. 6 Absorbance (nm) Saturation solubility in distilled water (µg/ml) + ethanol 0.576 50.0 (100%) + water +PVP K-30 0.197 17.1 (34%) 1:1 0.496 43.0 (86%) +PVP K-30 1:2 0.558 48.4 (97%) +PVP K-30 1:3 0.563 48.9 (98%) + 1:1 0.500 43.0 (86%) 7 + 1:2 0.545 47.0 (97%) 8 + 1:3 0.565 49.0 (98%) 9. 8. 9. + PEG-6000 1:1 0.274 23.8 (48%) + PEG -6000 1:2 0.398 34.5 (69%) + PEG-6000 1:3 0.400 34.7 (69%) 10 + Lactose 1:1 0.380 32.9 (66%) 11 + Lactose 1:2 0.480 41.7 (83%) 12 + Lactose 1:3 0.484 41.8 (83%) 13 + Sodium chloride 1:1 0.440 38.1 (76%) 14 + Sodium chloride 1:2 0.400 34.7 (69%) 15 + Sodium chloride 1:3 0.358 31.0 (62%) Available online: www.uptodateresearchpublication.com January - February 57

1.2 1 Absorbance ( nm ) 0.8 0.6 0.4 0.2 0 0 5 10 15 20 25 30 Concentration ( µg ) y = 0.0423x + 4E-05 R² = 1 Figure No.1: Standard graph of cefixime Absorbance ( nm) 1.2 1 0.8 0.6 0.4 0.2 0-0.2 0 5 10 15 20 25 30 Concentration ( µg ) y = 0.0408x -0.0035 R² = 0.9987 Figure No.2: Standard graph of omeprazole Available online: www.uptodateresearchpublication.com January - February 58

Saturation solubility in distilled water (µg/ml) 50 Concentration (µg/ml) 40 30 20 10 0 Ethano l water 01:0101:0201:0301:0101:0201:0301:0101:0201:0301:0101:0201:0301:0101:0201:03 Dg : PVP PVP PVP P EG60 00 P EG60 00 PEG6 000 lactos lacto e se lactos e Figure No.3: Saturation Solubility graph of Cefixime in water Saturation solubility in distilled water (µg/ml) 50 Concentration (µg/ml) 40 30 20 10 0 Ethan ol water 01:0101:0201:0301:0101:0201:0301:0101:0201:0301:0101:0201:0301:0101:0201:03 Dg : PVP PVP PE G6000 PE PE G6000 G6000 lacto se lacto se lacto se Figure No.4: Saturation Solubility graph of in water Available online: www.uptodateresearchpublication.com January - February 59

CONCLUSION In conclusion, solid dispersion of Cefixime and with solvent evaporation technique showed higher drug solubility in comparison to other technique like hot melt and slugging method. Hence this solid dispersion technique can be used to improve the dissolution and the bioavailability of given dosage forms. ACKNOWLEDGEMENT I am thankful to Seven Hills College of Pharmacy, Tirupati-517561, A.P, India for providing facility to carry out the research work CONFLICT OF INTEREST We declare that we have no conflict of interest. REFERENCES 1. Aulton, Aulton s Pharmaceutics. The Design and manufacture of medicine, 3rd edition, 293. 2. Noyes A A, Whitney W R. The rate of solution of solid substances in their own solutions, J Am Chem Soc, 19(12), 1897, 930 934. 3. Nernst W. Theorieder Reaktions geschwin digkeit in heterogenen systemen, Zeitschrift Physik Chemie, 47(1), 1907, 52 55. 4. Galia E, Nicolaides E, Horter D, Lobenberg R, Reppas C, Dressman B. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs, Pharm Res, 15(5), 1988, 698 705. 5. Sekiguchi K, Obi N. Studies on absorption of eutectic mixture, I.A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man, Chem Pharm Bull, 9(11), 1961, 866 867. 6. Craig Q M. The mechanisms of drug release from solid dispersions in water soluble polymers, Int.J. Pharm, 231(2), 2001, 131-144. 7. Parakh S R, Gothoskar A V. A review of mouth dissolving tablet technologies, Pharma Tech, 27(11), 2003, 92-100. 8. Higuchi T, Connors K. Phase-solubility techniques, Adv Anal Chem Instrum, 4, 1965, 117-212. 9. Dhirendra K, Lewis S, Udupa N et al. Solid Dispersions: A Review, Pak. J. Pharm. Sci, 22(2), 2009, 234-246. 10. Das S K, Saha S K, Das A, Halder A K, Banerjee S N, Chakraborty M. Solid dose, Journal of the Indian Medical Association, 106(9), 2008, 589-590. Please cite this article in press as: Shahid Mohammed S. et al. Compararission of solubility improvement of cefixime and omeprazole by solid dispersion and slugging method, International Journal of Research in Pharmaceutical and Nano Sciences, 3(1), 2014, 50-60. Available online: www.uptodateresearchpublication.com January - February 60